ERBB2 and cancer: As shown in Figure 1D, the top 10 core targets associated with CA and ALI were epidermal growth factor receptor (EGFR), caspase 3 (CASP3), multidrug resistance protein P‐glycoprotein (ABCB1), insulin‐like growth factor 1 receptor (IGF1R), matrix metalloproteinase 2 (MMP2), tyrosine kinase C (SRC), hepatocyte growth factor receptor (MET), vascular endothelial growth factor receptor 2 (KDR), matrix metalloproteinase 9 (MMP9), and tyrosine kinase receptor 2 (ERBB2).